These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 37370396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S, Fothergill JL, Wright EA, James CE, Mowat E, Winstanley C.
    J Vis Exp; 2012 Jun 05; (64):e3857. PubMed ID: 22711026
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.
    Gramegna A, Millar BC, Blasi F, Elborn JS, Downey DG, Moore JE.
    J Glob Antimicrob Resist; 2018 Sep 05; 14():224-227. PubMed ID: 29559421
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Sörensen M, Khakimov B, Nurjadi D, Boutin S, Yi B, Dalpke AH, Eigenbrod T.
    Antimicrob Resist Infect Control; 2020 Dec 09; 9(1):197. PubMed ID: 33298147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delafloxacin against Helicobacter pylori, a potential option for improving eradication success?
    Boyanova L, Markovska R, Medeiros J, Gergova G, Mitov I.
    Diagn Microbiol Infect Dis; 2020 Apr 09; 96(4):114980. PubMed ID: 31954595
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitis.
    Ribeiro ÁCDS, Santos FF, Valiatti TB, Lenzi MH, Santos INM, Neves RFB, Moses IB, Meneses JP, Di Sessa RGG, Salles MJ, Gales AC.
    Braz J Infect Dis; 2024 Apr 09; 28(6):103867. PubMed ID: 39305936
    [Abstract] [Full Text] [Related]

  • 14. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
    Ocheretyaner ER, Park TE.
    Expert Rev Anti Infect Ther; 2018 Jul 09; 16(7):523-530. PubMed ID: 29911455
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL, Weiser R, Powell LC, Forton J, Mahenthiralingam E, Rye PD, Hill KE, Thomas DW, Pritchard MF.
    mSphere; 2021 Jan 20; 6(1):. PubMed ID: 33472983
    [Abstract] [Full Text] [Related]

  • 16. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P, Citron DM, Griffith DC, Lomovskaya O, Dudley MN.
    Diagn Microbiol Infect Dis; 2010 Feb 20; 66(2):181-6. PubMed ID: 19828274
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum.
    Britt NS, Hazlett DS, Horvat RT, Liesman RM, Steed ME.
    Int J Antimicrob Agents; 2020 Apr 20; 55(4):105898. PubMed ID: 31931147
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A, Crocetta V, Verginelli F, Di Bonaventura G.
    FEMS Microbiol Lett; 2016 Jul 20; 363(14):. PubMed ID: 27242375
    [Abstract] [Full Text] [Related]

  • 20. Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.
    Atkin SD, Abid S, Foster M, Bose M, Keller A, Hollaway R, Sader HS, Greenberg DE, Finklea JD, Castanheira M, Jain R.
    Infect Drug Resist; 2018 Jul 20; 11():1499-1510. PubMed ID: 30271183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.